Aetna International appoints new CEO for EMEA region

Following the decision to merge its European and Middle East, and Africa divisions, Aetna International – a health insurance company – have appointed a new CEO to the newly create EMEA region.
David Healy joined the company in 2012 and became General Manager for the Europe Division, as well as the Vice President Head of Global Operations.
Aetna International have more than 900,000 members across the world, and Healy will be responsible for expanding international business, offering health benefits and health management solutions.
The CEO will have a team of more than 500 individuals within EMEA and will be responsible for working with the region’s strategic partners, governments, and health officials.
SEE ALSO:
Healy has more than 30 years of experience working with International Insurance and Employee Benefits Industries.
“In order to support our strategy to scale-up our capabilities, work with stakeholders on further developing healthcare infrastructure and create greater access to the right healthcare solutions, we have implemented a new structure by creating an EMEA region,” stated Mr Healy.
“Not only will this allow us to leverage our strengths and give our people the best environment to contribute and develop, it will also allow faster decision-making, more regional empowerment and accountability and put our customer groups at the heart of everything we do – including brokers.”
Prior to his current role, Healy worked for AEGON Ireland as Managing Director for life.
- Top 10: Biggest Pharma companies in EuropeMedical Devices & Pharma
- Royal Philips Middle East appoints Ozlem Fidanci as its new CEOTeleHealth & COVID-19
- Aetna International is set to take over Aviva UK’s IPMI divisionDigital Healthcare
- Tenet Healthcare CEO Trevor Fetter to step down in March 2018TeleHealth & COVID-19
Featured Articles
NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system
Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment
A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency